List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 530 studies with search of:   "Fludarabine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: fludarabine and rituximab;   Drug: fludarabine, rituximab, pixantrone
2 Recruiting Double Cord Blood Transplantation
Conditions: Leukemia;   Lymphoma;   Neuroblastoma;   Immunodeficiencies;   Anemia
Interventions: Drug: TBI, Thiotepa, Cyclophosphamide, ATG;   Drug: Busulfan, Melphalan, Rabbit ATG;   Drug: Busulfan, Fludarabine, Alemtuzumab;   Drug: Busulfan, Fludarabine, Rabbit ATG;   Drug: Fludarabine, Cyclophosphamide, ATG;   Drug: Busulfan, Cyclosphosphamide, Rabbit ATG,
3 Active, not recruiting Fludara Plus Alemtuzumab (Campath, MabCampath) vs Fludara Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
Condition: B-Cell Lymphocytic Leukemia
Interventions: Biological: alemtuzumab (Campath, MabCampath); FluCAM [Fludara + Campath];   Biological: fludarabine phosphate (Fludara)
4 Active, not recruiting Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor
Conditions: Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma;   Allogeneic Marrow Transplant
Interventions: Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
5 Recruiting Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
Conditions: AML;   MDS;   ALL;   CML;   Lymphoma
Intervention: Drug: fludarabine phosphate, busulfan
6 Recruiting Study Looking to See How Effective Fludarabine and Rituximab Followed by Bexxar Are for CLL or SLL
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
Interventions: Drug: Fludarabine;   Drug: Rituximab;   Drug: 131TOSITUMOMAB (BEXXAR®)
7 Recruiting A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Gene Directed Enzyme Prodrug Therapy, FP253/Fludarabine
8 Recruiting Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
Conditions: Richter's Transformation;   Leukemia
Interventions: Drug: Oxaliplatin;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Rituximab
9 Active, not recruiting Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Novantrone;   Drug: Decadron;   Drug: Rituximab;   Drug: Interferon;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Ara-C;   Drug: Methyl-Prednisolone;   Drug: Procarbazine;   Drug: Prednisone
10 Recruiting Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Cyclophosphamide;   Drug: Fludarabine
11 Recruiting Busulfan and Fludarabine Followed by Post-Transplant Cyclophosphamide
Conditions: Hematologic Diseases;   Leukemia;   Lymphoma;   Myeloma
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Cyclophosphamide
12 Active, not recruiting Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine Phosphate;   Drug: Cyclophosphamide;   Drug: Rituximab
13 Recruiting Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Interventions: Drug: Lenalidomide;   Drug: Fludarabine;   Biological: Rituximab
14 Recruiting Imatinib Mesylate, Busulfan, Fludarabine, and ATG for CML Patients
Condition: Leukemia
Interventions: Drug: Imatinib Mesylate;   Drug: Fludarabine;   Drug: Busulfan;   Drug: ATG
15 Recruiting Autologous and Allogeneic Transplant for Relapsed Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Hodgkins Disease
Interventions: Drug: Fludarabine and Busulfan;   Drug: Fludarabine, Busulfan and ATG
16 Recruiting Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin in CBF Leukemias
Condition: Acute Myelogenous Leukemia
Interventions: Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim (Neupogen, G-CSF);   Drug: Gemtuzumab Ozogamicin
17 Recruiting Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Mitoxantrone;   Drug: Rituximab;   Drug: Zevalin;   Drug: Dexamethasone
18 Recruiting Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: lenalidomide;   Drug: oral fludarabine phosphate;   Drug: rituximab
19 Recruiting Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
Conditions: Chronic Lymphocytic Leukemia;   Lymphoma;   Multiple Myeloma
Intervention: Drug: Fludarabine, Melphalan
20 Recruiting Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for AML and MDS
Conditions: Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Thymoglobulin;   Drug: Busulfan;   Drug: Fludarabine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services